Poly(3-hydroxybutyrate)/polyethylene glycol-NiO nanocomposite for NOR delivery: Antibacterial activity and cytotoxic effect against cancer cell lines
- 1 July 2018
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 114, 717-727
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- A Novel Magnetic Nanoparticle Drug Carrier for Enhanced Cancer ChemotherapyPLOS ONE, 2012
- Atypical fluoroquinolone gold(III) chelates as potential anticancer agents: Relevance of DNA and protein interactions for their mechanism of actionEuropean Journal of Medicinal Chemistry, 2012
- Current perspectives of nanoparticles in medical and dental biomaterialsJournal of Biomedical Research, 2012
- The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothingNucleic Acids Research, 2008
- Compatibilization through Specific Interactions and Dynamic Fragility in Poly(D,L‐lactide)/Polystyrene BlendsMacromolecular Chemistry and Physics, 2008
- Nanoparticle therapeutics: an emerging treatment modality for cancerNature Reviews Drug Discovery, 2008
- Drug delivery and nanoparticles: Applications and hazardsInternational Journal of Nanomedicine, 2008
- DNA topoisomerase II, genotoxicity, and cancerMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2007
- Mechanisms of Fluoroquinolone Resistance: An Update 1994-1998Drugs, 1999
- Side-effects of quinolones: Comparisons between quinolones and other antibioticsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991